Patent Assignment
Reel/Frame 069291/0729
Change of Name
Recorded: 2024-10-30
Pages: 4
Assignor
OCUPHIRE PHARMA, INC.
Executed: 2024-10-22
Assignee
OPUS GENETICS, INC.
37000 GRAND RIVER AVE. SUITE 120, FARMINGTON HILLS, MICHIGAN, 48335
Covered Property
(1)
Methods and Compositions for Treatment of Presbyopia, Mydriasis, and Other Ocular Disorders
Application:
17/230,270 →
Publication:
US 2021/0346349
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 24, 2021
From: PITLICK, WILLIAM H.; MEYER, ALAN R.; SOOCH, MINA; CHARIZANIS, KONSTANTINOS
To: OCUPHIRE PHARMA, INC.
Reel/Frame 056029/0353 →
Security Interest
Apr 21, 2026
From: OPUS GENETICS, INC.
To: OPCM SA LLC, AS PURCHASER AGENT FOR THE SECURED PARTIES
Reel/Frame 075478/0138 →